New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer
New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer have?
New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer has 30 citations in the OpenAlex counts ScholarIQ stores.
When was New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer published?
New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer has 2022 year in the ScholarIQ index.
What is the open-access status of New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer?
New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer has gold oa status in the ScholarIQ index.
What is the DOI of New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer?
The DOI for New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer is on the source record.
What is the PMID of New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer?
The PMID for New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer is on the source record.
What is the OpenAlex record for New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer?
The OpenAlex for New Advances in Nano-Drug Delivery Systems: Helicobacter pylori and Gastric Cancer is on the source record.